Menu
Recruiting NCT07637331

The Effect of Respiratory Muscle Training on Cognitive Performance

No phase Interventional Respiratory Muscle Training

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Inspiratory muscle training.
Who it may be relevant to
Registry conditions: Respiratory Muscle Training. Basic parameters: 18 years — 40 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Determine if exercise training for the respiratory muscles improves cognitive performance during periods when breathing against a resistance.

Interventions

  • Device Inspiratory muscle training
    8 weeks of active or sham inspiratory muscle training

Primary outcome measures

  • Diaphragm thickness [Time frame: Baseline and after 8 weeks of training]
  • Cognitive performance [Time frame: Baseline and after 8 weeks of training]
Secondary outcome measures (1)
  • Dyspnea [Time frame: Baseline and after 8 weeks of training]

Eligibility criteria

Inclusion criteria

  • 18-40 years old
  • Body mass index <30 kg/m2
  • Naïve to IMT
  • >75% of predicted forced expiratory volume in 1 second (FEV1) / forced vital capacity (FVC) (FEV1/FVC)
  • Access to smart phone or tablet with internet

Exclusion criteria

  • Diagnosed:
  • Cardiovascular disease
  • Respiratory disease (including asthma)
  • Metabolic disease
  • Currently pregnant
  • Unable to adhere to the IMT protocol
  • Answering 'yes' to any of the questions on page one of the PAR-Q+
  • Abnormal cognition assessed via the Montreal Cognitive Assessment (score of 25 or less)
  • Self-reported color blindness
  • Significant acute or chronic medical, neurologic, or illness in the participant that, in the judgment of the Principal Investigator, could compromise subject safety, limit the ability of the participant to complete the study, and/or compromise the objectives of the study

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Prevention

Study locations

United States · 1 center
  • Indiana University — Bloomington

Identifiers

NCT: NCT07637331 · 28083

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗